Norbrook Laboratories Ltd - Flunixin injection - ANADA 200-308 60644

Hazard statements (CLP)

H351, H372

Code

Statements

H351

Suspected of causing cancer

SECTION 2: Hazards identification

(29 CFR 1910.1200) Classification of the substance or mixture

Hazard statements

Carc. 2: H351 - Suspected of causing cancer. STOT RE 1: H372 - Causes damage to organs through prolonged or repeated exposure.

Precautionary statements

P201: Obtain special instructions before use. P202: Do not handle until all safety precautions have been read and understood. P260: Do not breathe vapours P264: Wash thoroughly after use. P270: Do no eat, drink or smoke when using this product. P308+P313 IF exposed or concerned Get medical advice/attention P314: Get medical advice/attention if you feel unwell. P501: Dispose of contents and / or containers in accordance with regulations on hazardous waste or packaging and packaging waste respectively.

Hazardous Ingredients

1-deoxy-1-(methylamino)-D-glucitol 2-[2-methyl-3-(perfluoromethyl)anilino]nicotinate (CAS: 42461-84-7); 2,2´-iminodiethanol (CAS: 111-42-2)

Additional information

WARNING 60644 SECTION 2: HAZARD(S) IDENTIFICATION (continued) This product can expose you to chemicals including 2,2´-iminodiethanol, which is [are] known to the State of California to cause cancer. For more information go to www.P65Warnings.ca.gov.

2.3 Other hazards

Non-applicable

2.1 Classification of the substance or mixture

29 CFR 1910.1200: Classification of the chemical in accordance with paragraph (d)(1)(i) of §1910.1200 Carc. 2: Carcinogenicity, Category 2, H351 STOT RE 1: Specific target organ toxicity, repeated exposure, Category 1, H372